Rationale: Twenty-eight percent of people with mild to moderate obstructive sleep apnea
experience daytime sleepiness, which interferes with daily functioning. It remains unclear …

Study objectives Continuous positive airway pressure (CPAP) therapy has become the
treatment of choice for obstructive sleep apnea (OSA). However, the efficacy of CPAP …

Rationale: To establish a new approach to investigate the physiological effects of obstructive
sleep apnea (OSA), and to evaluate novel treatments, during a period of continuous positive …

A common clinical dilemma faced by sleep physicians is in deciding the level of severity at
which patients with obstructive sleep apnea (OSA) should be treated. There is particular …

Background: It is unclear whether continuous positive airway pressure (CPAP), the treatment
of choice for severe obstructive sleep apnoea (OSA), is effective at improving outcomes in …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …

Background Obstructive sleep apnea is a relatively common disorder that can lead to lost
productivity and cardiovascular disease. The form of positive airway treatment that should be …

Manual continuous positive airway pressure (CPAP) titration in a sleep laboratory is costly
and limits access for diagnostic studies. Many factors affect CPAP compliance, but education …

Rationale: Continuous positive airway pressure (CPAP) is the current treatment for patients
with symptomatic obstructive sleep apnea (OSA). Its use for all subjects with sleep …

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients
with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with …